Εμφάνιση απλής εγγραφής

dc.contributor.author Μπάκα, Ειρήνη el
dc.contributor.author Πλούση, Αγάπη el
dc.contributor.author Αργυρού, Μαρία el
dc.contributor.author Βαλάση, Αλεξία el
dc.contributor.author Λιμούρης, Γεώργιος Σ. el
dc.date.accessioned 2015-02-14T15:30:13Z
dc.date.available 2015-02-14T15:30:13Z
dc.date.issued 2015-02-14
dc.identifier.uri http://hdl.handle.net/11400/6254
dc.rights Αναφορά Δημιουργού-Μη Εμπορική Χρήση-Όχι Παράγωγα Έργα 3.0 Ηνωμένες Πολιτείες *
dc.rights.uri http://creativecommons.org/licenses/by-nc-nd/3.0/us/ *
dc.source http://e-jst.teiath.gr/ en
dc.subject Individualized Dosimetry
dc.subject 177Lu-DOTA-octreotate
dc.subject Neuroendocrine tumors
dc.subject Peptide
dc.subject Receptor Radiotherapy
dc.subject Nuclear medicine
dc.subject Εξατομικευμένη Δοσιμετρία
dc.subject Νευροενδοκρινείς όγκοι
dc.subject Πεπτίδιο
dc.subject Ακτινοθεραπεία Υποδοχέων
dc.subject Πυρηνική ιατρική
dc.title Value of individualized dosimetry in peptide receptor radionuclide therapy (PRRT) by Lutetium-177 [177lu – Dota0, Tyr3] octreotate en
heal.type journalArticle
heal.classification Medicine
heal.classification Medical physics
heal.classification Ιατρική
heal.classification Ιατρική φυσική
heal.classificationURI http://id.loc.gov/authorities/subjects/sh00006614
heal.classificationURI http://id.loc.gov/authorities/subjects/sh85083001
heal.classificationURI **N/A**-Ιατρική
heal.classificationURI **N/A**-Ιατρική φυσική
heal.keywordURI http://id.loc.gov/authorities/subjects/sh94005134
heal.keywordURI http://id.loc.gov/authorities/subjects/sh85093011
heal.contributorName Λύρα, Μαρία el
heal.language en
heal.access free
heal.publicationDate 2014
heal.bibliographicCitation Baka, I., Ploussi, A., Argyrou, M., Valasi, A., Limouris, G.S., et al. (2014). Value of individualized dosimetry in peptide receptor radionuclide therapy (PRRT) by Lutetium-177 [177lu – Dota0, Tyr3] octreotate. "e-Journal of Science & Technology". [Online] 9(3): 43-49. Available from: http://e-jst.teiath.gr/ en
heal.abstract Response and toxicity prediction is essential to the implementation of Peptide Receptor Radionuclide Therapy (PRRT) for neuroendocrine tumors. Radiolabelled somatostatin analogue [177Lu-DOTA0 , Tyr3 ] octreotate stands as a promising therapy tool. Specific dosimetry is a crucial factor in patient treatment planning. In our Institution, neuroendocrine tumor treatment, by radiopeptide infusion via intrahepatic arterial catheterization, is a well established technique. Kidney protective agents are also included in our protocol. The individualized patient dosimetry calculations were based on planar and SPECT scintigraphy images. Counts were determined in a region of interest (ROI) around the tumor, liver, kidneys and spleen. In planar technique, the ROIs were drawn in both anterior and posterior images while in SPECT counts measured per slice. For counts conversion to activities, calibration factors were calculated. Planar and SPECT images of cylindrical water - filled phantom, with five different known amounts of activity, were obtained. Corrections for scatter attenuation, collimator efficiency and detector response were calculated. Absorbed doses were calculated using MIRD formalism and S values were calculated using the RADAR system. The absorbed doses to organ per unity administered activity were comparable for both planar and SPECT techniques. On average, the absorbed dose was in tumor [4- 40] mGy/ MBq, in kidneys[0.25-1.05] mGy/ MBq, in the spleen [0.3-2.1] mGy/ MBq and in the liver [0.05-0.34] mGy/ MBq. In order to deliver higher dose to tumor and avoid kidneys and red marrow toxicity, accurate individualized dosimetry is obligatory. Furthermore, the results quantitatively confirm the therapeutic efficacy of transhepatic administration and introduce 177Lu labeled peptide as an ideal for peptide receptor radiotherapy. en
heal.publisher Νερατζής, Ηλίας el
heal.publisher Σιανούδης, Ιωάννης el
heal.journalName e-Journal of Science & Technology en
heal.journalName e-Περιοδικό Επιστήμης & Τεχνολογίας el
heal.journalType peer-reviewed
heal.fullTextAvailability true


Αρχεία σε αυτό το τεκμήριο

Οι παρακάτω άδειες σχετίζονται με αυτό το τεκμήριο:

Εμφάνιση απλής εγγραφής

Αναφορά Δημιουργού-Μη Εμπορική Χρήση-Όχι Παράγωγα Έργα 3.0 Ηνωμένες Πολιτείες Εκτός από όπου ορίζεται κάτι διαφορετικό, αυτή η άδεια περιγράφεται ως Αναφορά Δημιουργού-Μη Εμπορική Χρήση-Όχι Παράγωγα Έργα 3.0 Ηνωμένες Πολιτείες